Literature DB >> 15596563

Predictors of quality-of-life benefit after percutaneous coronary intervention.

John A Spertus1, Adam C Salisbury, Philip G Jones, Darcy Green Conaway, Randall C Thompson.   

Abstract

BACKGROUND: Improving patients' quality of life is a primary indication for percutaneous coronary intervention (PCI), yet little is known about patient characteristics associated with greater quality-of-life improvement from the procedure. This study was conducted to identify patient characteristics associated with quality-of-life benefit after PCI. METHODS AND
RESULTS: A consecutive series of 1518 patients undergoing PCI in nonacute myocardial infarction settings were prospectively enrolled into an observational study documenting their postprocedural health status. We examined univariate and multivariable associations between baseline patient characteristics and quality of life 1 year after the procedure using the disease-specific Seattle Angina Questionnaire (SAQ) to quantify the impact of patients' coronary disease on their quality of life. Baseline angina frequency and physical function were the strongest predictors of quality-of-life improvement 1 year after PCI. In comparing patients without angina to those experiencing monthly, weekly, and daily angina, the quality-of-life improvements (mean+/-SEM) were 21.4+/-2.1, 30.7+/-2.2, and 34.6+/-2.6 points greater (P<0.001). Patients with mild, moderate, and severe physical limitation improved 13.8+/-1.9, 20.0+/-2.1, and 13.5+/-3.5 points more than those with minimal baseline physical limitation (P<0.001). These findings were maintained in multivariable models correcting for baseline differences in demographic, clinical, disease-severity, and health-status variables.
CONCLUSIONS: Preprocedural angina frequency is the most important prognostic indicator of quality-of-life improvement after PCI. Although substantial quality-of-life benefits are attained in most patients with preprocedural angina, more careful consideration of the potential benefits and risks of the procedure are needed in asymptomatic patients.

Entities:  

Mesh:

Year:  2004        PMID: 15596563     DOI: 10.1161/01.CIR.0000150392.70749.C7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  60 in total

1.  Relationship between the total length of the stents and patients' quality of life after percutaneous coronary intervention.

Authors:  Wei Liu; Xuming Yang; Pingshuan Dong; Zhijuan Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  The need to improve the appropriate use of coronary revascularization: challenges and opportunities.

Authors:  John Spertus; Paul Chan
Journal:  J Am Coll Cardiol       Date:  2012-05-22       Impact factor: 24.094

3.  Elective coronary stent patients: preinterventional functional status and clinical-instrumental assessment.

Authors:  Guglielmo M Trovato; Patrizia Pace; Corrado Tamburino; Giuliana Garufi; Giuseppe Fabio Martines; Clara Pirri; Francesca Trovato; Daniela Catalano
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

4.  Percutaneous coronary revascularisation: is it ever worth what it costs?

Authors:  Daniel B Mark
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

5.  Socioeconomic status, cognitive-emotional factors, and health status following myocardial infarction: testing the Reserve Capacity Model.

Authors:  Kymberley K Bennett; Donna M Buchanan; Philip G Jones; John A Spertus
Journal:  J Behav Med       Date:  2014-07-15

6.  Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention.

Authors:  S Michael Gharacholou; Veronique L Roger; Ryan J Lennon; Charanjit S Rihal; Jeff A Sloan; John A Spertus; Mandeep Singh
Journal:  Am J Cardiol       Date:  2012-03-20       Impact factor: 2.778

7.  De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status.

Authors:  Mohammed Qintar; Taishi Hirai; Suzanne V Arnold; Justin Sheehy; James Sapontis; Phil Jones; Yuanyuan Tang; William Lombardi; Dimitri Karmpaliotis; Jeffery Moses; Christian Patterson; William J Nicholson; David J Cohen; John A Spertus; J Aaron Grantham; Adam C Salisbury
Journal:  Am Heart J       Date:  2019-04-26       Impact factor: 4.749

8.  Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction.

Authors:  Kim G Smolderen; John A Spertus; Brahmajee K Nallamothu; Harlan M Krumholz; Fengming Tang; Joseph S Ross; Henry H Ting; Karen P Alexander; Saif S Rathore; Paul S Chan
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

9.  Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.

Authors:  Anna Grodzinsky; Mikhail Kosiborod; Fengming Tang; Philip G Jones; Darren K McGuire; John A Spertus; John F Beltrame; Jae-Sik Jang; Abhinav Goyal; Neel M Butala; Robert W Yeh; Suzanne V Arnold
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-09

10.  Canadian quality indicators for percutaneous coronary interventions.

Authors:  Dennis T Ko; Harindra C Wijeysundera; Xiaofu Zhu; Janice Richards; Jack V Tu
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.